Similar articles

• CHARISMA: the antiplatelet saga continues.

  Sacco S, Carolei A. Sacco S, et al. Stroke. 2007 Mar;38(3):854. doi: 10.1161/01.STR.0000259475.76373.42. Epub 2007 Feb 8. Stroke. 2007. PMID: 17290025 No abstract available.
• Antiplatelet therapy for patients with stents.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2008 Aug 11;50(1292):61-3. Med Lett Drugs Ther. 2008. PMID: 18688203 No abstract available.
• Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.

  Mohammad RA, Goldberg T, Dorsch MP, Cheng JW. Mohammad RA, et al. Clin Ther. 2010 Dec;32(14):2265-81. doi: 10.1016/j.clinthera.2011.01.003. Clin Ther. 2010. PMID: 21353100 Review.
• Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?

  Mohler ER 3rd. Mohler ER 3rd. Catheter Cardiovasc Interv. 2009 Jul 1;74 Suppl 1:S1-6. doi: 10.1002/ccd.21995. Catheter Cardiovasc Interv. 2009. PMID: 19213065 Review.
• Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.

  [No authors listed] [No authors listed] Prescrire Int. 2009 Dec;18(104):272-3. Prescrire Int. 2009. PMID: 20027714 No abstract available.